Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS : revenue, balance sheet and financial ratios

NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS is a French company founded 8 years ago, specialized in the sector Gestion de fonds. Based in CERGY (95800), this company of category PME shows in 2022 a revenue of 276 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS (SIREN 832900716)
Indicator 2022 2020 2019 2018 2017
Revenue 275 899 € N/C N/C N/C N/C
Net income -99 122 € -28 772 € -18 570 € -121 723 € -30 782 €
EBITDA -24 142 € -6 962 € -31 732 € -5 785 € -13 585 €
Net margin -35.9% N/C N/C N/C N/C

Revenue and income statement

In 2022, NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS achieves revenue of 276 k€. After deducting consumption (0 €), gross margin stands at 276 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -24 k€, representing -8.8% of revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Net income is negative at -99 k€ (-35.9% of revenue), which will impact equity.

Revenue (2022) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

275 899 €

Gross margin (2022) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

275 899 €

EBITDA (2022) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-24 142 €

EBIT (2022) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-20 372 €

Net income (2022) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-99 122 €

EBITDA margin (2022) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

-8.8%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 176%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 36%. The balance between equity and debt is satisfactory.

Debt ratio (2022) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

175.54%

Financial autonomy (2022) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

35.861%

Cash flow / Revenue (2022) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

-37.269%

Repayment capacity (2022) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

-49.538

Solvency indicators evolution
NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS

Sector positioning

Debt ratio
175.54 2022
2019
2020
2022
Q1: 0.01
Med: 15.74
Q3: 126.79
Average

In 2022, the debt ratio of NISSHA MEDICAL TECHNOLOGI... (175.54) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
35.86% 2022
2019
2020
2022
Q1: 12.13%
Med: 51.88%
Q3: 88.01%
Average

In 2022, the financial autonomy of NISSHA MEDICAL TECHNOLOGI... (35.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
-49.54 years 2022
2019
2020
2022
Q1: -0.05 years
Med: 0.0 years
Q3: 3.19 years
Excellent

In 2022, the repayment capacity of NISSHA MEDICAL TECHNOLOGI... (-49.54) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 1010.70. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2022) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

1010.697

Interest coverage (2022) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-385.399

Liquidity indicators evolution
NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS

Sector positioning

Liquidity ratio
1010.7 2022
2019
2020
2022
Q1: 96.29
Med: 394.11
Q3: 2450.04
Good +24 pts over 3 years

In 2022, the liquidity ratio of NISSHA MEDICAL TECHNOLOGI... (1010.70) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
-385.4x 2022
2019
2020
2022
Q1: -46.58x
Med: 0.0x
Q3: 0.0x
Average

In 2022, the interest coverage of NISSHA MEDICAL TECHNOLOGI... (-385.4x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 60 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 245 days. Excellent situation: suppliers finance 185 days of the operating cycle (retail model). Overall, WCR represents 1185 days of revenue, i.e. 908 k€ to permanently finance.

Operating WCR (2022) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

908 290 €

Customer credit (2022) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

60 j

Supplier credit (2022) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

245 j

Inventory turnover (2022) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2022) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

1185 j

WCR and payment terms evolution
NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS

Positioning of NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS in its sector

Comparison with sector Gestion de fonds

Valuation estimate

Based on 109 transactions of similar company sales in 2022, the value of NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS is estimated at 155 569 € (range 87 090€ - 341 835€). The price/revenue ratio is 0.56x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2022
109 transactions
87k€ 155k€ 341k€
155 569 € Range: 87 090€ - 341 835€
NAF 5 année 2022

Valuation method used

Revenue Multiple
275 899 € × 0.56x = 155 569 €
Range: 87 090€ - 341 836€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 109 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Gestion de fonds)

Compare NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS with other companies in the same sector:

Voir toutes les statistiques du secteur Gestion de fonds

Frequently asked questions about NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS

What is the revenue of NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS ?

The revenue of NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS in 2022 is 276 k€.

Is NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS profitable?

NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS recorded a net loss in 2022.

Where is the headquarters of NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS ?

The headquarters of NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS is located in CERGY (95800), in the department Val-d'Oise.

Where to find the tax return of NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS ?

The tax return of NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS operate?

NISSHA MEDICAL TECHNOLOGIES HOLDINGS SAS operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.